Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.

Kurek, Ralf

Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2004 - 5808-14 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-1004-03 doi


Antigens, Surface--blood
Case-Control Studies
DNA, Complementary--genetics
Glutamate Carboxypeptidase II--blood
Humans
Lymph Nodes--metabolism
Male
Neoplasm Staging
Prognosis
Prostate--metabolism
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
RNA, Messenger--blood
RNA, Neoplasm--blood
Reverse Transcriptase Polymerase Chain Reaction
Sensitivity and Specificity
Tissue Kallikreins--blood
Tumor Cells, Cultured